REMODULIN (TREPROSTINIL) INJECTION
Live / Registered — Registered and renewed (as of 28 Feb 2021)
What this means for you
Registered since 30 Nov 2010. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 30 Nov 2020).
Record
- Serial number
- 77352192
- Registration number
- 3883260
- Mark type
- Design + words
- Filed
- 14 Dec 2007
- Published for opposition
- 27 May 2008
- Registered
- 30 Nov 2010
- Next maintenance due
- 30 Nov 2020
- Attorney of record
- Norm J. Rich
Goods and services
- Class 005 — Pharmaceuticals: Cardiovascular pharmaceuticals
Owner
- United Therapeutics Corporation, Silver Spring, MD, US
- United Therapeutics Corporation, Silver Spring, MD, US
- United Therapeutics Corporation, Silver Spring, MD, US
Prior registrations
Prosecution history
- 28 Feb 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 28 Feb 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 28 Feb 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 28 Feb 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Nov 2020 — TEAS SECTION 8 & 9 RECEIVED
- 30 Nov 2019 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 19 Dec 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 19 Dec 2016 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 19 Dec 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Oct 2016 — TEAS SECTION 8 & 15 RECEIVED
- 30 Nov 2010 — REGISTERED-PRINCIPAL REGISTER
- 26 Oct 2010 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Oct 2010 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 22 Oct 2010 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Oct 2010 — DATA MODIFICATION COMPLETED